MetaCap

Innospec Financial Ratios

NASDAQ: IOSPIndustrialsMajor ChemicalsUSD

95.65-2.04 (-2.09%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Innospec ratio analysis

Innospec earned a net margin of 6.6% in FY 2025, up from 1.9% a year earlier. Gross margin was 27.7% compared with a median of 29.9% over the prior 9 years. Return on equity reached 8.8%, meaning Innospec generated 0.09 dollars of profit for every dollar of shareholders' equity.

At the end of FY 2025, IOSP traded at 16.3 times earnings; across the 10 fiscal years shown, its year-end P/E ranged from 16.3 to 78.2, with a median of 22.4. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.

Summary generated from market data by MetaCap's automated system. Methodology

Innospec financial ratios (annual)

Innospec annual financial ratios
RatioFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
P/E ratio (at fiscal year end)16.3376.6922.1719.3324.0978.2222.6718.1928.0220.57
Price / sales1.071.471.571.301.501.871.671.041.301.86
Price / book1.432.242.672.462.162.36—1.862.152.52
Gross margin27.7%29.4%30.3%29.9%29.3%28.7%30.8%29.5%30.9%37.6%
Operating margin7.3%9.6%8.3%9.5%8.9%2.8%9.9%9.0%9.6%11.1%
Net margin6.6%1.9%7.1%6.8%6.3%2.4%7.4%5.8%4.7%9.2%
Free cash flow margin4.9%7.8%7.5%2.1%3.6%9.7%8.7%5.1%4.5%10.1%
Return on equity (ROE)8.8%2.9%12.1%12.8%9.0%3.0%—10.3%7.8%12.4%
Return on assets (ROA)6.4%2.1%8.1%8.3%5.9%2.1%7.6%5.8%4.4%6.9%
Debt / equity—————0.00—0.250.280.41
Current ratio2.792.582.382.152.162.242.082.242.152.41
Revenue growth-3.7%-5.3%-0.8%32.4%24.3%-21.2%2.5%13.0%47.9%-12.7%
EPS growth228.9%-74.5%4.5%41.9%223.3%-74.4%31.6%36.9%-24.3%-31.5%

Related